FIELD: medicine. SUBSTANCE: pyruvate dehydrogenase activity in leucocyte and platelet mitochondria is determined. Initial degree of insulin-resistance, moderate degree and expressed degree are diagnosed at enzyme activity values: 19.6-23.0; 16.5-19.0 and 13.5-16.0 mmole/l/h, respectively. EFFECT: increased precision of assay. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CARRYING OUT IMMUNOSUPPRESSIVE DIAGNOSIS OF ENDOGENOUS DEPRESSION STATES | 1992 |
|
RU2042950C1 |
| METHOD FOR ENDOGENOUS PSYCHOSIS TREATMENT | 0 |
|
SU1641351A1 |
| METHOD FOR COMPLEX CORRECTION OF COMORBID PATHOLOGY IN PERIMENOPAUSAL WOMEN | 2019 |
|
RU2703137C1 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME WITH DEPRESSIVE DISORDERS | 2013 |
|
RU2550724C1 |
| USING CANNABINOIDS COMBINED WITH ANTIPSYCHOTIC DRUG PREPARATION | 2008 |
|
RU2503448C2 |
| LABORATORY METHOD OF DIAGNOSING BIPOLAR AFFECTIVE DISORDER | 2013 |
|
RU2558056C2 |
| METHOD OF ESTIMATION OF PATIENT'S MENTAL CONDITION WITH ENDOGENIC MENTAL DISORDERS AT THEIR CLINICAL EXAMINATION AND METHOD OF COMPLEX EVALUATION OF THE STATE OF THE IMMUNE SYSTEM OF SUCH PATIENTS | 2016 |
|
RU2648745C1 |
| METHOD FOR DIAGNOSING ENDOGENOUS PSYCHOSES | 1999 |
|
RU2153290C1 |
| METHOD FOR TREATING PATIENTS SUFFERING FROM ABDOMINAL OBESITY WITH APPLYING MAGNETIC-LASER THERAPY WITHIN INTEGRATED RESORT TREATMENT | 2008 |
|
RU2373917C1 |
| NEUROTROPIC MEDICINAL AGENT | 1999 |
|
RU2171116C2 |
